reason report
onward upward power growth execut new
bottom line rais pt post solid
immin close fide success growth strategi
deliv ep beat consensu estim
 driven beat lower estim share count partial
off-set miss sg tax rate guidanc lower
driven delay fide close partial off-set better expect
perform appear conservat rais
estim growth
strategi execut remain differenti solid contract win
latest fl core compet success roll-up power
envolv pbm manag specialti servic platform
risk peakish exchang margin downgrad
bullish tax reform guidanc remain hard argu
best breed player solid secular growth stori grow
success across organ inorgan driver next day
june nyc
solid ep beat in-lin revenu beat
driven strong beat lower estim share
count partial off-set miss sg tax rate compani
report adj ep versu consensu estim
delay equiti rais fide acquisit contribut
ep revenu in-lin expect come medic
membership increas qoq driven increas hix
membership expans new state exhibit
metric consolid beat consensu bp
beat partial off-set bp miss sg higher
expect tax rate lower expect despit flu-rel
headwind bp larg driven increas exposur
exchang busi rel earn
compar quarter compani also experienc better
expect perform medicaid busi day claim
payabl solid increas day yoy sequenti
full year guidanc lower driven delay fide
close ep guidanc lower
 revenu guidanc lower midpoint delay
fide acquisit contribut decreas ep
guidanc partial off-set better manag expect
perform fide transact expect close
net debt total capit
price-to-earnings lt ep growth
ep
gener long term ep growth period
compani inform leerink partner llc research
revenu billion adj ep
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
fide close immin accret mm
mm compani recent got approv ny
depart depart financi servic
fide transact step away deal closur view
await approv ny attorney gener certain
close condit pleas see link note link exhibit
medicaid contract win continu emerg success fl re-
procur award announc yesterday along wcg
region comprehens plan region
specialti segment pleas see link flash note fl medicaid
award link earlier year contract nm
new entrant also success reprocur az expand
presenc state pleas see link note mn contract award
link pleas see link note az contract award link
upcom key award wa tx due may
exchang growth exce expect mm hix
member grow membership yoy higher
compani expect mm compani presenc hix
rais estim post solid rais estim
 ep estim
mid-point updat guidanc rang
conserv view sooner juli close fide offer
growth strategi across roll-up differenti specialti
servic envolv platform continu ceo allud potenti
accret profit convers top bottom line growth
expect doubl digit percent rang equiti stake rx advanc
cloud base pbm synergist broader envolv platform in-
hous pbm medic manag servic roll-up strategi offer
two dimens growth base busi integr
envolv platform right expand equiti
margin across hix downgrad tax reform guidanc
could pose downsid risk earn
mask impress growth across organ inorgan driver
flow solid power balanc sheet cfo
adjust net incom came debt capit
secondari offer fuel fide acquisit time may
deal close expect juli
valuat still offer upsid growth multipl
expans current year forward price-to-earnings june day
catalyst rais pt contempl price-to-earnings
ep exhibit
rais pt post solid immin close fide
success growth strategi deliv
ep beat consensu estim driven beat lower
estim share count partial off-set miss sg tax rate guidanc lower
 driven delay fide close partial off-set better expect perform
appear conservat rais estim
growth strategi execut remain differenti solid contract win latest
fl core compet success roll-up power envolv pbm
manag specialti servic platform risk peakish exchang margin
downgrad bullish tax reform guidanc remain hard argu best
breed player solid secular growth stori grow success across organ
inorgan driver next day june nyc
beat driven strong beat lower estim share count
partial off-set miss sg tax rate
compani report adj ep versu consensu estim delay equiti
rais fide acquisit contribut ep revenu in-lin expect
come medic membership increas qoq driven increas hix
membership expans new state
report ep in-lin revenu
metric consolid beat consensu bp beat partial off-set
bp miss sg higher expect tax rate
lower expect despit flu-rel headwind bp larg driven
increas exposur exchang busi rel earn
compar quarter compani also experienc better expect perform
medicaid busi
day claim payabl solid increas day yoy sequenti
ep driven partial off-set miss sg tax rate
corpearningsreport estimatesstreet account consensusreport sequentialreport yoypremium servic revenu revenu ep share interest expens invest incom estim corpmetricsreport estimatesstreet account consensusreport sequentialreport yoykey metricsconsolid bpsservic revenu bpsadj bpstax bpsday claim cfo/net corpor
day claim payabl improv sequenti yoy
membership growth driven growth exchang membership
full year guidanc lower driven delay fide close ep guidanc
lower revenu guidanc lower
midpoint delay fide acquisit contribut decreas ep guidanc
partial off-set better manag expect perform fide
transact expect close juli
full year guidanc lower due delay fide close partial off-set better
dec feb april estim -newconsensu estimatestot revenu expens ratio expens ratio excl acquisit relat tax share outstand compani guidanc centen corpor
driver guidanc chang
fide close immin accret mm mm
compani recent got approv ny depart depart
servic fide transact step away deal closur view
await approv ny attorney gener certain close condit
driver guidanc chang
emerg success fl re-procur award announc yesterday along
wcg region comprehens plan region specialti
earlier year contract nm new entrant also success re-
procur az expand presenc state upcom key award wa tx
due may
said million first year made comment today target get half say million year two alway target higher level synergi felt comfort million today- jeffrey schwanek evp cfo treasur centen corp con call centen corpor
market share wa area re-procur due
tx market share largest player
mm hix member grow membership yoy higher
compani expect mm compani presenc hix market
compani exchang footprint state
rais estim ep
estim mid-point updat guidanc rang
conserv view sooner juli close fide offer upsid
rais ep estim respect
guidanc conserv offer upsid
reportedconsensusleerinkconsensusleerinkrevenu incom non-gaap growth rememb includ anoth month overhang right compar last guidanc includ anoth month share debt overhang number probabl larger expect addit month overhang second point would go prepar remark think fide perform exactli expect reiter accret target far share price updat would say two thing compar announc transact septemb last year share price interest expens bond rate move us share price move favor would tell believ rel conserv expect rais capit sit today jeffrey schwanek evp cfo treasur centen corp con call centen corpor
growth strategi across roll-up differenti specialti servic envolv platform
continu ceo allud potenti accret profit convers top bottom
line growth expect doubl digit rang equiti stake rx advanc cloud-bas pbm
synergist broader envolv platform in-hous pbm medic manag
servic roll-up strategi offer two dimens growth base busi
integr envolv platform right expand equiti invest
envolv compani differenti specialti servic platform contribut
ceo allud continu accret acquisit part growth strategi
margin across hix downgrad tax reform guidanc could pose downsid risk
earn mask impress growth across organ
march made equiti invest rxadvanc full-servic pharmaci benefit manag rxadvanc complementari intern pbm expect use compani cloud-based technolog platform significantli reduc administr cost avoid drug-impact medic cost partnership includ custom relationship strateg invest rxadvanc part initi transact certain right expand equiti invest futur interpreta march acquir addit ownership interpreta bring total ownership interpreta innov health compani focus clinic genom data well real-tim analyt summari net effect acquisit invest continu execut diversif strategi proven abil acquir effect integr acquisit size expect grow top bottom line double-digit percentag anticip margin continu expand maintain focu process effici autom increas scale michael neidorff chairman ceo corp con call corpor
hix margin pose risk earn exposur mid-teen
membership cnc rate
decreas
pose headwind
hix memebership hix revenu pmpm revenu exposur hix pre-tax pre-tax incom ep exposur ep exposur hix ratingscnc membership rate ratingscnc membership rate centen corpor
flow solid power balanc sheet cfo adjust net incom came
debt capit secondari offer fuel fide acquisit time
may deal close expect juli
debt equiti end
valuat still offer upsid growth multipl expans current year
forward price-to-earnings june day catalyst rais pt
contempl price-to-earnings ep
trade price-to-earnings consensu ep estim rais pt
contempl price-to-earnings ep estim
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
multipl expans use absolut rel price-to-earnings multipl base approach valuat
ep estim combin price-to-earnings base approach dcf model point
intrins valu compani plu add premium deal probabl
price target repres price-to-earnings ep
downsid risk invest thesi valuat aet legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn
upsid risk invest thesi valuat aet accret acquisit
aggress share repurchas use solid parent cash posit debt rais
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
new pt contempl price-to-earnings ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
base price-to-earnings multipl appli stand-alone ep rate ci
outperform price target
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
pt reflect price-to-earnings averag ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
centen corpor incom statement except oper tax health insur sale firstguard cnc-hnt transact incom net incom net averag share ep dilut growth profit growth centen corpor
